# Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors

> **NCT00353977** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 38 (actual)

## Conditions studied

- Cytomegalovirus Infections

## Interventions

- **BIOLOGICAL:** ALVAC-CMV (vCP260)

## Key facts

- **NCT ID:** NCT00353977
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00353977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00353977, "Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00353977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*